ELVN
Enliven Therapeutics Inc
$296K
Single sell
Discretionary Insider Activity
Date:
03/06/2026
Insiders:
Hohl Benjamin, CHIEF FINANCIAL OFFICER
Prior trend:
21 months of no discretionary insider activity

Summary

A $296K single sell for Enliven Therapeutics Inc (ELVN) on 03/06/2026 after 21 months of no discretionary insider activity.

Reports

Action Amount Date Insider Role(s) SEC Filing No
Sell $296K 03/10/2026 Hohl Benjamin CHIEF FINANCIAL OFFICER 0001882764-26-000002

Stake Changes

Action Insider Role(s) Total Change % Change
Sell Hohl Benjamin CHIEF FINANCIAL OFFICER $296K 16.4%

Transactions

Action Amount Date Insider Security Type SEC Code
Sell $296K 03/06/2026 Hohl Benjamin Common Stock Discretionary Sale

Metadata

Signal ID:
5uopJ1gRWRS1B3vb
Scanned on:
04/01/2026
Status:
Current